Author

Michelle C. Hedin

Observed names: Hedin, Michelle C, Michelle C Hedin

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5068408566

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19

2021 · Raymund R. Razonable, Colin Pawlowski, et al. · EClinicalMedicine · 126

Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019

2022 · Raymund R Razonable, Ravindra Ganesh, et al. · Journal of Patient Experience · 4

Works count: 4

Citation count: 130

H-index: 2

I10-index: 1